PCNZ

Pharmaceutical Manufacturing • Auckland, Auckland, New Zealand • 11-20 Employees

Company overview

Headquarters	Auckland, Auckland, New Zealand
Phone number	+6494421727
Websites	pharmaceutical.co.nz compoundlabs.co.nz
NAICS	3254
SIC	591
Keywords	Pain, Integrative Medicine, Hormone Imbalance, Custom Medicines
Founded	1998
Employees	11-20
Socials

Key Contacts at PCNZ

Denis Kay

Director

Daniel Newman

Director

PCNZ Email Formats

PCNZ uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 42.1% of the time.

Format	Example	Percentage
{first name}.{last name}@company.com	john.doe@company.com	42.1%
{first name}@company.com	john@company.com	25.3%
{first name initial}{last name}@company.com	{first name initial}doe@company.com	14.8%
{first name}{last name}@company.com	johndoe@company.com	10.2%
{last name}@company.com	doe@company.com	7.6%

About PCNZ

PCNZ (Pharmaceutical Compounding NZ Limited) was the first dedicated compounding pharmacy established in New Zealand (1998) specialising in the production of custom medicines. Our vision is to be the leaders in providing quality personlised options to those seeking to enhance their individual health and wellness. Our area of expertise is hormone imbalances (but not limited to) menopause, andropause, hypothyroidism, insomnia and fatigue. Other areas include autism, pain and nutraceutical supplementation. We work with patients and practitioners and offer expert advice on treatments options. We understand that your individual needs are unique. We also host public seminars (see our website), distribute an E-newsletter on health and attend national and international conferences to learn the latest research and approaches to be a resource for patients, doctors and pharmacists.

PCNZ revenue & valuation

Annual revenue	$5,902,740
Revenue per employee	$492,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$18,900,000
Total funding	No funding